Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model

Por Pishali Bejestani, Elham, Cartellieri, Marc, Bergmann, Ralf, Ehninger, Armin, Loff, Simon, Kramer, Michael, Spehr, Johannes, Dietrich, Antje, Feldmann, Anja, Albert, Susann, Wermke, Martin, Baumann, Michael, Krause, Mechthild, Bornhäuser, Martin, Ehninger, Gerhard, Bachmann, Michael, von Bonin, Malte
Publicado no Oncoimmunology (2017)

Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells

Por Bachmann, Dominik, Aliperta, Roberta, Bergmann, Ralf, Feldmann, Anja, Koristka, Stefanie, Arndt, Claudia, Loff, Simon, Welzel, Petra, Albert, Susann, Kegler, Alexandra, Ehninger, Armin, Cartellieri, Marc, Ehninger, Gerhard, Bornhäuser, Martin, von Bonin, Malte, Werner, Carsten, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael
Publicado no Oncotarget (2017)

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”

Por Feldmann, Anja, Arndt, Claudia, Bergmann, Ralf, Loff, Simon, Cartellieri, Marc, Bachmann, Dominik, Aliperta, Roberta, Hetzenecker, Mirjam, Ludwig, Florian, Albert, Susann, Ziller-Walter, Pauline, Kegler, Alexandra, Koristka, Stefanie, Gärtner, Sebastian, Schmitz, Marc, Ehninger, Armin, Ehninger, Gerhard, Pietzsch, Jens, Steinbach, Jörg, Bachmann, Michael
Publicado no Oncotarget (2017)